MiniMed Files for IPO, Separation from Medtronic
Update: 2025-12-19
Description
MiniMed Group, a diabetes management company, is set to go public after filing for an IPO, separating from Medtronic. Despite a net loss of $21 million, revenues surged to $1.5 billion, marking improvement from the previous year. MiniMed, known for its automated insulin pumps and continuous glucose monitors, generated $2.7 billion in fiscal 2025. Medtronic will retain 80.1% voting power post-IPO, with shares expected to trade on Nasdaq under MMED.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
